Your browser doesn't support javascript.
loading
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Cordero, Alberto; Fernández Olmo, Mª Rosa; Cortez Quiroga, Gustavo A; Romero-Menor, Cesar; Fácila, Lorenzo; Seijas-Amigo, José; Rondán Murillo, Juan; Sandin, Miriam; Rodríguez-Mañero, Moisés; Bello Mora, María C; Valle, Alfonso; Fornovi, Aisa; Freixa Pamias, Roman; Bañeras, Jordi; Blanch García, Pedro; Clemente Lorenzo, María Milagros; Sánchez-Álvarez, Sergio; López-Rodríguez, Luis; González-Juanatey, José R.
Affiliation
  • Cordero A; Cardiology Department, Hospital Universitario de San Juan, Alicante, Spain.
  • Fernández Olmo MR; Unidad de Investigación en Cardiología, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain.
  • Cortez Quiroga GA; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
  • Romero-Menor C; Cardiology Department, Complejo Hospitalario de Jaén, Jaén, Spain.
  • Fácila L; Cardiology Department, Hospital Alto Guadalquivir, Jaén, Spain.
  • Seijas-Amigo J; Cardiology Department, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain.
  • Rondán Murillo J; Cardiology Department, Consorcio Hospital General de Valencia, Valencia, Spain.
  • Sandin M; Cardiology Department, Complejo Hospitalario Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
  • Rodríguez-Mañero M; Cardiology Department, Hospital Universitario de Cabueñes, Gijón, Spain.
  • Bello Mora MC; Cardiology Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • Valle A; Cardiology Department, Complejo Hospitalario Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
  • Fornovi A; Cardiology Department, Hospital de Alava, Vitoria, Spain.
  • Freixa Pamias R; Cardiology Department, Hospital Universitario de Denia, Denia, Spain.
  • Bañeras J; Endocrinology Department, Hospital Vega Baja, Orihuela, Spain.
  • Blanch García P; Cardiology Department, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
  • Clemente Lorenzo MM; Cardiology Department, Hospital del Vall Hebrón, Barcelona, Spain.
  • Sánchez-Álvarez S; Cardiology Department, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain.
  • López-Rodríguez L; Cardiology Department, Hospital Virgen del Puerto de Plasencia, Plasencia, Spain.
  • González-Juanatey JR; Cardiology Department, Hospital Hospital Lluis Alcanys Xátiva, Valencia, Spain.
Eur J Clin Invest ; 52(12): e13863, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36039486
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proprotein Convertase 9 / PCSK9 Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Invest Year: 2022 Document type: Article Affiliation country: España Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proprotein Convertase 9 / PCSK9 Inhibitors Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Eur J Clin Invest Year: 2022 Document type: Article Affiliation country: España Country of publication: Reino Unido